Lubis H R, Silalahi M
Curr Med Res Opin. 1986;10(4):221-7. doi: 10.1185/03007998609110442.
Twenty patients with mild to severe essential hypertension completed a 12-week open crossover study to compare the effectiveness and tolerance of two beta-blocker/diuretic combinations. Patients were allocated at random to receive treatment for 6 weeks with either 40 mg propranolol plus 12.5 mg hydrochlorothiazide twice daily or 400 mg acebutolol plus 25 mg hydrochlorothiazide once daily. They were then crossed over to the alternative medication for a further 6 weeks. Blood pressures and pulse rate were monitored in the supine and erect positions at regular intervals, as were side-effects, laboratory variables and ECG. The results showed that both combinations produced significant reductions from baseline in systolic and diastolic blood pressures but that the acebutolol combination produced a significantly greater reduction in diastolic blood pressure. There was no evidence of a treatment sequence effect. The two drug treatments were reasonably well tolerated, with a trend in favour of the acebutolol combination. No clinically significant changes were observed in any of the laboratory parameters investigated and there were no ECG abnormalities.
20例轻至重度原发性高血压患者完成了一项为期12周的开放交叉研究,以比较两种β受体阻滞剂/利尿剂组合的有效性和耐受性。患者被随机分配,接受为期6周的治疗,每日两次服用40mg普萘洛尔加12.5mg氢氯噻嗪,或每日一次服用400mg醋丁洛尔加25mg氢氯噻嗪。然后,他们交叉使用另一种药物,再进行6周的治疗。定期监测仰卧位和直立位的血压和脉搏率,以及副作用、实验室指标和心电图。结果显示,两种组合均使收缩压和舒张压较基线水平显著降低,但醋丁洛尔组合使舒张压降低更为显著。没有证据表明存在治疗顺序效应。两种药物治疗的耐受性都较好,有倾向于醋丁洛尔组合的趋势。在所研究的任何实验室指标中均未观察到具有临床意义的变化,也没有心电图异常。